Organogenesis Holdings Inc (ORGO) is 6.44% away from 50-day simple Moving Average despite all headwinds

Organogenesis Holdings Inc (NASDAQ: ORGO) kicked off on Monday, up 5.21% from the previous trading day, before settling in for the closing price of $3.65. Over the past 52 weeks, ORGO has traded in a range of $1.79-$4.70.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Annual sales at Healthcare sector company grew by 24.79% over the past five years. While this was happening, its average annual earnings per share was recorded -66.78%. With a float of $79.01 million, this company’s outstanding shares have now reached $130.92 million.

Organogenesis Holdings Inc (ORGO) Insider and Institutional Ownership

Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Organogenesis Holdings Inc is 40.16%, while institutional ownership is 37.61%. The most recent insider transaction that took place on Jan 10, was worth 76,875. In this transaction 10% Owner of this company sold 17,972 shares at a rate of $4.28, taking the stock ownership to the 59,007,134 shares. Before that another transaction happened on Jan 10, when Company’s 10% Owner sold 17,972 for $4.28, making the entire transaction worth $76,875. This insider now owns 59,007,134 shares in total.

Organogenesis Holdings Inc (ORGO) Latest Financial update

Wall Street market experts anticipate that the next fiscal year will bring earnings of 32.40 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -66.78% per share during the next fiscal year.

Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators

Take a look at Organogenesis Holdings Inc’s (ORGO) current performance indicators. Last quarter, stock had a quick ratio of 2.43. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.13.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.10, a number that is poised to hit 0.01 in the next quarter and is forecasted to reach 0.07 in one year’s time.

Technical Analysis of Organogenesis Holdings Inc (ORGO)

Organogenesis Holdings Inc (NASDAQ: ORGO) saw its 5-day average volume 0.59 million, a negative change from its year-to-date volume of 0.67 million. As of the previous 9 days, the stock’s Stochastic %D was 90.35%. Additionally, its Average True Range was 0.22.

During the past 100 days, Organogenesis Holdings Inc’s (ORGO) raw stochastic average was set at 68.49%, which indicates a significant decrease from 97.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.56% in the past 14 days, which was lower than the 79.68% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $3.63, while its 200-day Moving Average is $3.17. Nevertheless, the first resistance level for the watch stands at $3.94 in the near term. At $4.04, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.22. If the price goes on to break the first support level at $3.66, it is likely to go to the next support level at $3.48. The third support level lies at $3.38 if the price breaches the second support level.

Organogenesis Holdings Inc (NASDAQ: ORGO) Key Stats

The company with the Market Capitalisation of 507.03 million has total of 132,041K Shares Outstanding. Its annual sales at the moment are 450,890 K in contrast with the sum of 15,530 K annual income. Company’s last quarter sales were recorded 108,530 K and last quarter income was 3,170 K.